Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N C Pedersen

Showing results (181-190 of 191) with videos related to

Pageof 20
Sort By:
Journal of Virology|November 1, 1994
A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challengeB L Lohman, M B McChesney, C J Miller, et al.
AIDS Research and Human Retroviruses|June 27, 1998
Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaquesK K Van Rompay, M L Marthas, J D Lifson, et al.
Journal of Virology|November 1, 1986
Prevention of simian acquired immune deficiency syndrome with a formalin-inactivated type D retrovirus vaccineP A Marx, N C Pedersen, N W Lerche, et al.
Journal of Virology|March 12, 1999
Early short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine treatment favorably alters the subsequent disease course in simian immunodeficiency virus-infected newborn Rhesus macaquesK K van Rompay, P J Dailey, R P Tarara, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1996
9-[2-(Phosphonomethoxy)propyl]adenine therapy of established simian immunodeficiency virus infection in infant rhesus macaquesK K Van Rompay, J M Cherrington, M L Marthas, et al.
Journal of Virology|January 22, 2000
Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPAK K Van Rompay, M D Miller, M L Marthas, et al.
Journal of Virology|October 24, 2000
Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motifC M Leutenegger, F S Boretti, C N Mislin, et al.
Journal of Wildlife Diseases|February 26, 1998
Bartonella henselae antibody prevalence in free-ranging and captive wild felids from CaliforniaK Yamamoto, B B Chomel, L J Lowenstine, et al.
AIDS (London, England)|September 14, 2000
Protection against FIV challenge infection by genetic vaccination using minimalistic DNA constructs for FIV env gene and feline IL-12 expressionF S Boretti, C M Leutenegger, C Mislin, et al.
AIDS Research and Human Retroviruses|June 27, 1998
Lessons from the cat: feline immunodeficiency virus as a tool to develop intervention strategies against human immunodeficiency virus type 1J H Elder, G A Dean, E A Hoover, et al.
Pageof 20

Showing results (181-190 of 191) with videos related to

Sort By:
Pageof 20
Journal of Virology|November 1, 1994
A partially attenuated simian immunodeficiency virus induces host immunity that correlates with resistance to pathogenic virus challengeB L Lohman, M B McChesney, C J Miller, et al.
AIDS Research and Human Retroviruses|June 27, 1998
Administration of 9-[2-(phosphonomethoxy)propyl]adenine (PMPA) for prevention of perinatal simian immunodeficiency virus infection in rhesus macaquesK K Van Rompay, M L Marthas, J D Lifson, et al.
Journal of Virology|November 1, 1986
Prevention of simian acquired immune deficiency syndrome with a formalin-inactivated type D retrovirus vaccineP A Marx, N C Pedersen, N W Lerche, et al.
Journal of Virology|March 12, 1999
Early short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine treatment favorably alters the subsequent disease course in simian immunodeficiency virus-infected newborn Rhesus macaquesK K van Rompay, P J Dailey, R P Tarara, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1996
9-[2-(Phosphonomethoxy)propyl]adenine therapy of established simian immunodeficiency virus infection in infant rhesus macaquesK K Van Rompay, J M Cherrington, M L Marthas, et al.
Journal of Virology|January 22, 2000
Prophylactic and therapeutic benefits of short-term 9-[2-(R)-(phosphonomethoxy)propyl]adenine (PMPA) administration to newborn macaques following oral inoculation with simian immunodeficiency virus with reduced susceptibility to PMPAK K Van Rompay, M D Miller, M L Marthas, et al.
Journal of Virology|October 24, 2000
Immunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motifC M Leutenegger, F S Boretti, C N Mislin, et al.
Journal of Wildlife Diseases|February 26, 1998
Bartonella henselae antibody prevalence in free-ranging and captive wild felids from CaliforniaK Yamamoto, B B Chomel, L J Lowenstine, et al.
AIDS (London, England)|September 14, 2000
Protection against FIV challenge infection by genetic vaccination using minimalistic DNA constructs for FIV env gene and feline IL-12 expressionF S Boretti, C M Leutenegger, C Mislin, et al.
AIDS Research and Human Retroviruses|June 27, 1998
Lessons from the cat: feline immunodeficiency virus as a tool to develop intervention strategies against human immunodeficiency virus type 1J H Elder, G A Dean, E A Hoover, et al.
Pageof 20